Yaqrit is a biotech company developing liver disease treatments. Its technology focuses on the removal of bacterial endotoxins from the blood and from the gut. The company offers Carbalive, a macroporous carbon delivered in sachets that binds to, and thereby removes, LPS from the gut, and Dialive, extracorporeal liver support for acute-on-chronic liver failure that removes LPS from the blood and exchanges damaged albumin for fresh albumin.